Study for People Who Take an SGLT2 Medication
Do you have type 2 diabetes?
Are you taking metformin with or without a SGLT2 medication (like Invokana, Farxiga, Jardiance, Steglatro, Brenzavvy)?
You could consider participating in this open label study evaluating the effectiveness of two injectable research medications in terms of glucose control and weight loss. There are no placebos in this trial.
What Does this Study Require?
- Study commitment of up to 77 weeks with 15 office visits and at least 6 phone calls.
- Injection of investigational study medicine with an easy-to-use injection pen once a week
- Multiple blood draws and finger sticks (glucose meter and supplies provided)
- Maintain a dosing diary and complete questionnaires using a study app
Who Can Participate?
- Must be 18 and older with a diagnosis of type 2 diabetes for more than 6 months
- Taking metformin alone or in combination with a SGLT2 inhibitor (Invokana, Farxiga, Jardiance, Steglatro, Brenzavvy)
- BMI > 30 with a HbA1c 7.0- 10.5%
How to Learn More
You may call our office at 615-329-2222 and speak with our team or fill out our form below. Our team will need to speak with you to determine if you are interested and qualify for participation in this research study.
Potential Patient Benefits
All diagnostic tests and study medication are at no cost.
Compensation of $2,150 may be available for participants in this study.
Please fill out our form below.
Our team will be in touch with you as soon as possible to discuss the study.